Psychiatry

Latest in Psychiatry

Tardive Dyskinesia

Dopamine Receptor–Blocking Agent Exposure in the Pathophysiology of Tardive Dyskinesia

clinical topic updates
By Andrew J. Cutler, MD

Tardive Dyskinesia

Antipsychotic Switching Strategies in Tardive Dyskinesia

clinical topic updates
By Andrew J. Cutler, MD

Tardive Dyskinesia

Clinical Trials, Long-term Follow-up, and Experience With VMAT2 Inhibitors

clinical topic updates
By Andrew J. Cutler, MD

Tardive Dyskinesia

Choosing the Right Treatment for Tardive Dyskinesia

expert roundtables
By Andrew J. Cutler, MD; Leslie Citrome, MD, MPH; Rakesh Jain, MD, MPH

Tardive Dyskinesia

Degree of Reversibility of Tardive Dyskinesia

expert roundtables
By Andrew J. Cutler, MD; Leslie Citrome, MD, MPH; Rakesh Jain, MD, MPH